Unknown

Dataset Information

0

Dual Diagnosis of Ellis-van Creveld Syndrome and Hearing Loss in a Consanguineous Family.


ABSTRACT: Multilocus analysis of rare or genetically heterogeneous diseases is a distinct advantage of next-generation sequencing (NGS) over conventional single-gene investigations. Recent studies have begun to uncover an under-recognized prevalence of dual molecular diagnoses in patients with a "blended" phenotype that is the result of 2 clinical diagnoses involving 2 separate genetic loci. This blended phenotype could be mistakenly interpreted as a novel clinical extension of a single-gene disorder. In this study, we ascertained a proband from a large consanguineous Iranian family who manifests postlingual, progressive, moderate hearing loss in addition to suspected Ellis-van Creveld syndrome phenotype. NGS with a customized skeletal dysplasia panel containing over 370 genes and subsequent bioinformatics analysis disclosed 2 homozygous mutations in EVC2 (c.2653C>T; p.Arg885*) and COL11A2 (c.966dup; p.Thr323Hisfs*19), respectively. This study highlights a dual molecular diagnosis in a patient with a blending of 2 distinct phenotypes and illustrates the advantage and importance of this staple technology to facilitate rapid and comprehensive genetic dissection of a heterogeneous phenotype. The differentiation between phenotypic expansion of a genetic disorder and a blended phenotype that is due to more than one distinct genetic aberration is essential in order to reduce the diagnostic odyssey endured by patients.

SUBMITTER: Vona B 

PROVIDER: S-EPMC5803684 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dual Diagnosis of Ellis-van Creveld Syndrome and Hearing Loss in a Consanguineous Family.

Vona Barbara B   Maroofian Reza R   Mendiratta Geetu G   Croken Matthew M   Peng Siwu S   Ye Xiaoqian X   Rezazadeh Jamileh J   Bahena Paulina P   Lekszas Caroline C   Haaf Thomas T   Edelmann Lisa L   Shi Lisong L  

Molecular syndromology 20170922 1


Multilocus analysis of rare or genetically heterogeneous diseases is a distinct advantage of next-generation sequencing (NGS) over conventional single-gene investigations. Recent studies have begun to uncover an under-recognized prevalence of dual molecular diagnoses in patients with a "blended" phenotype that is the result of 2 clinical diagnoses involving 2 separate genetic loci. This blended phenotype could be mistakenly interpreted as a novel clinical extension of a single-gene disorder. In  ...[more]

Similar Datasets

| S-EPMC1891277 | biostudies-literature
| S-EPMC4428735 | biostudies-other
| S-EPMC3354796 | biostudies-literature
| S-EPMC3207784 | biostudies-literature
| S-EPMC3022156 | biostudies-literature
| S-EPMC3886354 | biostudies-literature
| S-EPMC6732296 | biostudies-literature
| S-EPMC6372401 | biostudies-literature
| S-EPMC3214960 | biostudies-literature
| S-EPMC2671989 | biostudies-literature